Files

No attached file found for this publication.

Details

Authors
Abstract
The present invention relates to serine biosynthetic pathway inhibitors such as phosphoglycerate dehydrogenase inhibitors and phosphoserine aminotransferase 1 inhibitors, and to theses inhibitors for use as a medicament, more in particular for the prevention or treatment of cellular proliferative disorders.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Frédérick, R., Ravez, S., Spillier, Q., Corbet, C., & Feron, O. (n.d.). Serine biosynthetic pathway inhibitors. https://hdl.handle.net/2078.5/260968